Skip to main content

Advertisement

Table 5 Consistency characteristics of guidelines

From: Current guidelines on the management of gestational diabetes mellitus: a content analysis and appraisal

Guidelines N Mean (SD)
C1* C2* C3*
NICE 74 6.93 (0.34) 6.96 (0.26) 6.96 (0.26)
NZGG 38 6.55 (0.76) 6.39 (0.82) 6.53 (0.65)
SIGN 18 5.78 (1.11) 6.00 (0.91) 4.67 (0.59)
ADA 17 1.00 (0.00) 2.65 (1.17) 3.18 (1.24)
FIGO 40 1.20 (0.72) 1.83 (1.65) 3.45 (2.33)
Endocrine Society 25 5.04 (1.72) 6.68 (1.25) 5.88 (1.81)
CDA 17 3.53 (2.43) 4.18 (2.40) 3.88 (1.69)
API 22 5.45 (2.22) 5.45 (2.22) 5.04 (2.38)
IDF 13 1.00 (0.00) 3.38 (2.29) 2.77 (1.24)
Queensland 8 1.75 (0.71) 3.88 (1.36) 3.13 (1.25)
HKCOG 13 1.00 (0.00) 1.23 (0.60) 1.15 (0.55)
A.N.D. 15 6.00 (0.00) 5.67 (0.49) 5.93 (0.26)
DDG 21 1.05 (0.22) 1.43 (0.75) 2.24 (1.30)
CMA 40 1.00 (0.00) 1.30 (0.72) 1.15 (0.48)
Total 361 4.00 (2.74) 4.43 (2.59) 4.49 (2.42)
  1. C1*: consistency between search strategy and selection of evidence
  2. C2*: consistency between selected evidence and interpretation
  3. C3*: consistency between interpretation and resulting recommendations